Lawsuit claims Novo Nordisk delayed generic Victoza using patent tactics and settlements, preserving monopoly pricing and ...
The Food and Drug Administration on Tuesday published a list of more than 200 brand name drugs without generic alternatives on the market. While the list leaves many drugmakers susceptible to more ...
Generic drugs are the rare part of American health care that actually drives down costs. In 2024, they accounted for 90 ...
The Food and Drug Administration on Tuesday published a list of brand name drugs without generic competition and implemented a policy to accelerate generic drug approvals. The actions represent the ...
Lawsuit alleges a 2019 settlement delayed Teva's generic Victoza launch, with plaintiffs seeking unspecified monetary damages ...
Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. AbbVie announced this morning it has settled litigation ...
The city of Baltimore is suing Biogen over allegedly scheming with pharmacy benefit managers (PBMs) to stave off generic competition for its multiple sclerosis treatment, Tecfidera. In a class action ...
Ashley L. Cole is a doctoral candidate in the Division of Pharmaceutical Outcomes and Policy, Eshelman School of Pharmacy, and a predoctoral fellow at the Cecil G. Sheps Center for Health Services ...
Amneal Pharmaceuticals (NYSE:NASDAQ:AMRX), a commercial-stage biopharmaceutical company with a market capitalization of $2.53 billion, has been positioning itself for a new phase of multi-year growth ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results